Cytoreductive surgery and HIPEC (hyperthermic intraperitoneal chemotherapy) in combined treatment of ovarian cancer: time for the beginning of personalized therapy?

Cytoreductive surgery and HIPEC (hyperthermic intraperitoneal chemotherapy) in combined treatment of ovarian cancer: time for the beginning of personalized therapy?

Background and objectives. During the two past decades, a new therapeutic approach to ovarian cancer (OC) has been developed. This combines cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). However, almost no data exist regarding the utility of biomarkers of morpholo...

Full description

Bibliographic Details
Main Authors: Yarema Roman, Volodko Nataliya, Fetsych Taras, Оhorchak Myron, Petronchak Orest, Mylyan Yuriy, Makukh Halyna
Format: Article
Language:English
Published: Sciendo 2019-09-01
Series:Current Issues in Pharmacy and Medical Sciences
Subjects:
ovarian cancer
peritoneal carcinomatosis
cytoreductive surgery
hyperthermic intraperitoneal chemotherapy
p53
brca 1
Online Access:http://www.degruyter.com/view/j/cipms.2019.32.issue-3/cipms-2019-0028/cipms-2019-0028.xml?format=INT

Internet

http://www.degruyter.com/view/j/cipms.2019.32.issue-3/cipms-2019-0028/cipms-2019-0028.xml?format=INT

Similar Items